Nanostring CONTACT US CAREERS Search PRODUCTS RESEARCH FOCUS RESOURCES SUPPORT COMPANY Investor Relations NASDAQ: NSTG 41.62 -0.99 ( -2.32% ) Pricing delayed by 20 minutes INVESTOR MENU Corporate Profile NanoString Technologies is a leading provider of life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System is used in life sciences research and has been cited in more than 2,300 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. The company's technology is also being used in diagnostics. The Prosigna® Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer. Recent Press Releases NanoString Launches nCounter TCR Diversity Panel and Analysi... November 11, 2021 NanoString to Webcast Presentation from the Stifel 2021 Virt... November 10, 2021 NanoString Releases Operating Results for Third Quarter of 2... November 9, 2021 VIEW ALL PRESS RELEASES Latest Quarterly Results Third Quarter 2021 Press Release (opens in new window) GAAP to Non-GAAP reconciliation for 2021 (opens in new window) Financial Results Webcast (opens in new window) Form 10-Q (opens in new window) Presentation (opens in new window) VIEW ALL QUARTERLY RESULTS Events & Webcasts Stifel 2021 Virtual Healthcare Conference November 15, 2021 | 04:40 PM ET Webcast (opens in new window) NanoString Third Quarter 2021 Financial Results November 9, 2021 | 01:30 PM PT Webcast (opens in new window) NanoString Technologies presents at the 19th Annual Global Healthcare Conference September 9, 2021 | 02:45 PM ET Webcast (opens in new window) VIEW ALL EVENTS & WEBCASTS Latest Presentation Nanostring 2021 Third Quarter Financial Results November 9, 2021 Download (opens in new window) Investor Contact Phone: 1 888-358-NANO (6266) Fax: 206-378-6288 General Investor Inquiries: investorrelations@nanostring.com Email Alerts YOUR EMAIL Press Releases Events Presentations SEC Filings Quarterly & Annual Reports End of Day Stock Quote SIGN UP Nanostring Catalyzing the next biological revolution to improve the human condition. Copyright © 2021 NanoString. All rights reserved Quick Links Publications Events Investors Careers Contact Us Legal Site Map Address 530 Fairview Ave N, Seattle, WA 98109 CONTACT US Facebook LinkedIn Twitter YouTube Powered By Q4 Inc. 5.56.0.1 (opens in new window)